AstraZenecas weekly-once diabetes drug gets U.S. approval for children – Reuters

July 23 (Reuters) – AstraZeneca Plc (AZN.L) said on Friday its diabetes drug Bydureon was approved in the United States for use in patients as young as age 10 to help reduce blood sugar levels along … [+396 chars]

Leave a Reply

Your email address will not be published. Required fields are marked *